Skip to main content
Fig. 3 | Clinical Epigenetics

Fig. 3

From: Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes

Fig. 3

Volcano plots of recurrence-free survival (RFS) associated CpGs from the epigenome-wide association study (EWAS) analyses. The Cox multivariable model that was fitted in EWAS was shown in each plot. CpGs are colored in red (A) 12,105 CpGs were associated with the increased hazard of NMIBC 10-year RFS, and 15,470 CpGs were associated with the decreased hazard of NMIBC 10-year RFS. (B) 1572 CpGs were associated with the increased hazard of NMIBC 10-year RFS, and 956 CpGs were associated with the decreased hazard of NMIBC 10-year RFS

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us